IASR Vol. 41,
No.9 (No. 487) September 2020
No.9 (No. 487) September 2020
Rubella and congenital rubella syndrome in Japan as at July 2020
- Future actions on the elimination of rubella, with FY2020 set as the target year
- Response to a rubella outbreak at a host club located in an entertainment district, Tokyo
- Response to a rubella outbreak at a Japanese language school, Nagoya City
- Characteristics of 5 congenital rubella syndrome patients born in January 2019 – June 2020, Japan
- Survey on the implementation status of rubella virus genetic tests at local public health institutes, Japan
- External quality assessment operations, Japan (for measles and rubella tests)
- Rubella vaccination status and seroprevalence in Japan, FY2019—National Epidemiological Surveillance of Vaccine-Preventable Diseases (provisional results)
- Immunization status for measles and rubella (MR) combined vaccine among children during the COVID-19 pandemic, Japan
- Global situation of rubella and congenital rubella syndrome
- Results from the active epidemiological investigation on COVID-19, Japan (First report) (as at 3 June 2020, provisional)
- Detection of Baloxavir-resistant PA E23K-mutated influenza virus from Baloxavir-untreated patients, Japan
- Outbreak of parainfluenza virus in a ward for individuals with severe motor and intellectual disabilities, Toyama City
- Evaluation of infectivity based on isolation of SARS-CoV-2 from COVID-19 patients, Hiroshima City
- Characteristics of household transmission of SARS-CoV-2, Okinawa Prefecture